Pacer Advisors
TNGX icon

Pacer Advisors’s Tango Therapeutics TNGX Stock Holding History

Pacer Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Buy
+1,338
New +$33.1K ﹤0.01% 2078
2024
Q3 		– Sell
-415
Closed -$3.56K – 2697
2024
Q2 		$3.56K Sell
415
-607
-59% -$4.69K ﹤0.01% 3660
2024
Q1 		$8.12K Buy
+1,022
New +$11K ﹤0.01% 3564

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Pacer Advisors's TNGX Position: Q2 2026 in Review

Pacer Advisors opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 1,338 shares worth $42K. The stake represents ﹤0.01% of the portfolio and ranks #2078 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in TNGX as recently as Q2 2024.

Pacer Advisors first reported a position in TNGX in Q1 2024 and has held it in 3 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Pacer Advisors held 1,338 shares of Tango Therapeutics worth $42K as of Q2 2026.
  • Tango Therapeutics was a new Pacer Advisors position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2078 holding.
  • Pacer Advisors first reported a position in Tango Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.